Wordt geladen...
Feasibility of Administering High-Dose (131)I-MIBG Therapy to Children with High-Risk Neuroblastoma without Lead-Lined Rooms
BACKGROUND: Although (131)I-metaiodobenzylguanidine therapy ((131)I-MIBG) is increasingly used for children with high-risk neuroblastoma, a paucity of lead-lined rooms limits its wider use. We implemented radiation safety procedures to comply with New York City Department of Health and Mental Hygien...
Bewaard in:
| Gepubliceerd in: | Pediatr Blood Cancer |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4801722/ https://ncbi.nlm.nih.gov/pubmed/26773712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25892 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|